Search & Filter

One in five people admitted to hospital for angina, stroke, heart attack or heart failure have diabetes, according to a new report published today.

Accident and emergency (A&E) waiting times hit the headlines this month when NHS England announced it had missed its four-hour A&E waiting time target with performance dropping to its lowest level for a decade.

NICE has issued a draft guideline to set out the most effective way to diagnose asthma and how healthcare professionals can help adults, children and young people better control their symptoms.

A new pre-filled pen for the administration of the once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist Bydureon® (exenatide once-weekly) has been launched.

The National Institute for Health and Care Excellence (NICE) has recommended eculizumab (Soliris) for treating a rare life-threatening blood disorder called atypical Haemolytic Uraemic Syndrome (aHUS).

NICE has recommended rivaroxaban in final draft guidance as an option for preventing blood clots in people who have had an acute coronary syndrome (ACS).

The first national recruitment video to encourage medical students to choose general practice as a career has been launched by the Royal College of General Practitioners (RCGP).

Cancer deaths in children and young people have fallen by 58 per cent in the past 40 years, according to new figures announced by Cancer Research UK today.

The January 2015 meeting of the Committee for Medicinal Products for Human Use (CHMP) saw 7 new medicines have been recommended for approval.

A virus similar to those found in bats may be the cause of a severe brain infection in children whose immune systems are low, according to research. 

A new oral therapy for psoriasis and its related joint condition, psoriatic arthritis, has been granted marketing authorisation from the European Commission.

There are 2.9 million people aged 65 and over who feel they have no one to go to for help and support, a new Age UK survey finds.

UK scientists have taken steps to overcome drug resistance in glioblastoma, the most common type of brain tumour in adults, according to research published in Molecular Cancer Therapeutics.

Two new treatment options for patients with hepatitis C are a step closer to being recommended for use in the NHS, following draft guidance from the National Institute for Health and Care Excellence (NICE).

Up to a quarter of patients with bowel cancer who have a family history of the disease could have the causes of their cancer identified through gene testing, a new study reports.